"It is the Massachusetts story — early-stage companies developing great science, commercial giants with a local presence, and financial partnerships that turn ideas into treatments."
"We have recognized the synergies between the life science and tech industries, and have worked to foster relationships that can accelerate therapeutic, medical device and diagnostic development."
"Ohio is increasingly competitive in attracting larger, well-known life science brands, plus our institutions continue to spin out new biotech companies; people across the country are starting to notice."
"Arizona has seen a surge of investor interest, with new government funding sources now available and fast-tracking permitting options helping many copper development projects."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.